Castle DJ

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

7 papers · ORCID

ArticlePsilocybin

Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.

Ledwos N, Baer J, Husain MI +11

Europe PMC2025
ArticleMDMA

Aggressive behaviours associated with MDMA and psychedelics: a narrative review.

Sayrafizadeh N, Ledwos N, Husain MI +1

Europe PMC2024
ArticlePsilocybin

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.

Husain MI, Blumberger DM, Castle DJ +8

Europe PMC2023
ArticlePsilocybin

Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?

Rossell SL, Meikle SE, Williams ML +1

Europe PMC2023
ArticlePsilocybin

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

Husain MI, Ledwos N, Fellows E +5

Europe PMC2022
ArticlePsychedelics

Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder.

Ledwos N, Rodas JD, Husain MI +2

Europe PMC2023
ArticlePsilocybin

A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.

Ledwos N, Rosenblat JD, Blumberger DM +4

Europe PMC2022